암 치료의 나노기술 : 각종 기술과 세계 시장

The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.

Report Scope

This report provides detailed information about nanotechnology in the cancer treatment market. The report analyzes the market trends for nanotechnology in cancer treatment with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report highlights nanotechnology in cancer treatment's current and future market potential and analyzes the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities. The report also covers market estimates for 2029 and market shares for key players.

The market scope in this report is segmented into product type and cancer types. Based on product type, the market is segmented into liposomes, polymeric nanoparticles, micelles, hydrogels, and dendrimers. The market is segmented by cancer type into lungs, breast, leukemia, lymphoma, melanoma and other cancers.

The market has been segmented into the following regions: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment includes a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. For market projections, data will be provided for 2023 as the base year, with forecasts for 2024 through 2029.

The report's goals include:

• Analyzing product and cancer type.
• Analyzing global market size and segments.
• Reviewing market constraints and drivers.
• Providing detailed market forecasts for 2029.
• Assessing market shares, competitiveness and industry structure.
• Identifying potential long-term impacts on nanotechnology in the cancer treatment market.

Report Includes

• Analyses of the trends in global markets for nanotechnology in cancer treatment, with revenue data for 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
• Estimates of the size and revenue prospects for the global market, along with a market share analysis by product type, application and region
• Facts and figures pertaining to the global market dynamics, technological advances, regulations and standards, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Information pertaining to evolving trends and patterns, recent technological breakthroughs, and the types of nanostructured materials, nanodevices, and nanotools used for research, diagnosis and therapy of the types of cancer
• Statistics regarding the incidence and prevalence of cancer cases, as well as global mortality figures
• Analysis of relevant patents and patent grants
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Patent Analysis
• Analysis of Porter's Five Forces
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry
• Future Perspective

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Prevalence of Cancer Cases Globally
• Rise in Government Funding and Pharmaceutical R&D Spending
• Nanoparticles in Cancer Treatment: Advantages
• Precision Targeting of Cancer Cells with Nanomaterials
• Market Restraints
• Roadblocks to Clinical Nanoparticle Use
• Lack of Oncology Professionals
• Market Opportunities
• Mechanism of Nanoparticles in Overcoming Drug Resistance
• Cancer Proteomics

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Japan

Chapter 5 Emerging Technologies and New Developments

• Emerging Trends and Technologies
• Artificial Intelligence
• Quantum Dots
• Oncology Products Pipeline

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Global Market Size and Forecast
• Liposomes
• Polymeric Nanoparticles
• Micelles
• Hydrogels
• Dendrimers
• Market Analysis by Cancer Type
• Global Market Size and Forecast
• Lung Cancer
• Breast Cancer
• Leukemia
• Lymphoma
• Melanoma
• Other Cancers
• Geographic Breakdown
• Market Analysis by Region
• Global Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Chapter 7 Competitive Intelligence

• Overview
• Competitive Landscape

Chapter 8 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ASTRAZENECA
• BAXTER
• BOSTON SCIENTIFIC CORP.
• BRISTOL-MYERS SQUIBB CO.
• F. HOFFMANN-LA ROCHE LTD.
• JAZZ PHARMACEUTICALS INC.
• LES LABORATOIRES SERVIER
• NOVARTIS AG
• PFIZER INC.
• TEVA PHARMACEUTICAL INDUSTRIES LTD.
• Other Emerging Players